Insulin degludek: Perbedaan antara revisi

Konten dihapus Konten ditambahkan
Muhammad Anas Sidik (bicara | kontrib)
←Membuat halaman berisi '{{Infobox drug | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 476995027 | image = Insulin degludec hexamer 4AKJ.png | alt = | caption = An insulin degludec hexamer. A chains are chartreuse, B chains are tan, and the central zinc atom is teal. From {{PDB|4AKJ}}. <!-- Clinical data -->| pronounce = | tradename = Tresiba | Drugs.com = {{Drugs.com|monograph|insulin-degludec}} | MedlinePlus = a615055 | DailyMedID = Insulin degludec |...'
Tag: tanpa kategori [ * ] Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan
 
Muhammad Anas Sidik (bicara | kontrib)
Tidak ada ringkasan suntingan
Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan
Baris 94:
 
Obat ini tercantum dalam Daftar Obat Esensial Organisasi Kesehatan Dunia sebagai padanan insulin glargine.<ref name="WHO23rd">{{cite book | vauthors = ((World Health Organization)) | title = The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023) | year = 2023 | hdl = 10665/371090 | author-link = World Health Organization | publisher = World Health Organization | location = Geneva | id = WHO/MHP/HPS/EML/2023.02 | hdl-access=free }}</ref>
==Sejarah==
==Kegunaan dalam medis==
==Efek samping==
==Farmakologi==
==Profil efektivitas==
==Data uji klinis==
==Farmakoekonomi==
==Referensi==
{{reflist|refs=
 
<ref name=CHMP2012>{{Cite web |date=18 October 2012 |title=Summary of opinion 1 (initial authorisation): Tresiba |type=PDF |work=Pending EC decisions |publisher=[[European Medicines Agency]] |url=http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/002498/WC500134060.pdf |access-date=6 November 2012 |author=Committee for Medicinal Products for Human Use |archive-date=11 January 2017 |archive-url=https://web.archive.org/web/20170111004707/http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/002498/WC500134060.pdf }}</ref>
 
}}
[[Category:Human proteins]]
[[Category:Insulin receptor agonists]]
[[Category:Peptide hormones]]
[[Category:Peptide therapeutics]]
[[Category:Recombinant proteins]]